Stay updated with breaking news from Markus Zeitlinger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: invIOs GmbH / Key word(s): Study results invIOs GmbH: APEIRON Respiratory Therapies announces positive results from Phase I trial of inhaled APN01 03.11.2022 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. APEIRON Respiratory Therapies announce...
APEIRON Biologics commences clinical COVID-19 trial with inhaled APN01 Inhalation of APN01 to directly target SARS-CoV-2 virus in respiratory tract, the lung and tissue itselfPrimary objective is to evaluate safety and tolerability of inhaled APN01Phase 1 trial to enroll about 40 healthy volunteersAdditional US Phas...
DGAP-News: APEIRON Biologics AG / Key word(s): Study12.10.2021 / 08:00 The issuer is solely responsible for the content of this announcement.APEIRON Biologics commences clinical COVID-19 trial with inhaled APN01 Inhalation of APN01 to directly target SARS-CoV-2 virus in respiratory tract, the lung and tissue itself...
Weltweit läuft die Suche nach potenten Wirkstoffen gegen Covid-19 auf Hochtouren. US-Forscher haben jetzt eine überraschende Entdeckung gemacht.